The three PGRN centers are listed below alphabetically by principal investigator:
Center for Pharmacogenomics of Statin Therapy Ronald Krauss, MD, Children’s Hospital Oakland Research Institute (Calif.) Aldons Jake Lusis, PhD, University of California, Los Angeles Center for Precision Medicine in Leukemia Mary V. Relling, PharmD, St. Jude Children’s Research Hospital, Memphis, Tenn. Mignon Loh, MD, University of California Benioff Children's Hospital Center for Improving Prediction of Drug Action Dan M. Roden, Vanderbilt University School of Medicine, Nashville, Tenn. Elizabeth J. Phillips, MD, Vanderbilt University School of Medicine, Nashville, Tenn. Joshua C. Denny, MD, MS, Vanderbilt University School of Medicine, Nashville, Tenn. PGRN enabling resources are listed below alphabetically by principal investigator: PharmGKB: Pharmacogenomics Knowledge for Precision Medicine Russ Altman, MD, PhD, Stanford University Teri Klein, PhD, Stanford University PGRN Hub Kathy Giacomini, PhD, University of California San Francisco Graham Johnson, PhD, University of California San Francisco F-CAP: Functionalization of Variants in Clinically Actionable Pharmacogenes Doug Fowler, University of Washington Allan Rettie, University of Washington Clinical Pharmacogenetics Implementation Consortium (CPIC) Mary V. Relling, PharmD, St. Jude Children’s Research Hospital, Memphis, Tenn. Teri Klein, PhD, Stanford University |
AuthorThe Hub team Archives
November 2019
Categories
All
|